Literature DB >> 19924112

Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats.

Gregory V Carr1, Debra A Bangasser, Thelma Bethea, Matthew Young, Rita J Valentino, Irwin Lucki.   

Abstract

The Wistar Kyoto (WKY) rat strain is a putative genetic model of comorbid depression and anxiety. Previous research showing increased kappa-opioid receptor (KOR) gene expression in the brains of WKY rats, combined with studies implicating the KOR in animal models of depression and anxiety, suggests that alterations in the KOR system could have a role in the WKY behavioral phenotype. Here, the effects of KOR antagonists in the forced swim test (FST) were compared with the WKY and the Sprague-Dawley (SD) rat strains. As previously reported, WKY rats showed more immobility behavior than SD rats. The KOR antagonists selectively produced antidepressant-like effects in the WKY rats. By contrast, the antidepressant desipramine reduced immobility in both strains. Brain regions potentially underlying the strain-specific effects of KOR antagonists in the FST were identified using c-fos expression as a marker of neuronal activity. The KOR antagonist nor-binaltorphimine produced differential effects on the number of c-fos-positive profiles in the piriform cortex and nucleus accumbens shell between SD and WKY rats. The piriform cortex and nucleus accumbens also contained higher levels of KOR protein and dynorphin A peptide, respectively, in the WKY strain. In addition, local administration of nor-binaltorphimine directly into the piriform cortex produced antidepressant-like effects in WKY rats further implicating this region in the antidepressant-like response to KOR antagonists. These results support the use of the WKY rat as a model of affective disorders potentially involving KOR overactivity and provide more evidence that KOR antagonists could potentially be used as novel antidepressants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19924112      PMCID: PMC2813986          DOI: 10.1038/npp.2009.183

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  59 in total

1.  Development of a strain of spontaneously hypertensive rats.

Authors:  K OKAMOTO; K AOKI
Journal:  Jpn Circ J       Date:  1963-03

2.  Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects.

Authors:  Brian A Hoshaw; Jessica E Malberg; Irwin Lucki
Journal:  Brain Res       Date:  2005-03-10       Impact factor: 3.252

3.  Identification of novel electroconvulsive shock-induced and activity-dependent genes in the rat brain.

Authors:  Woong Sun; Kun Woo Park; Jeehyung Choe; Im Joo Rhyu; Il Hwan Kim; Soon Kwon Park; Byungil Choi; Sang-Hyun Choi; Sun Hwa Park; Hyun Kim
Journal:  Biochem Biophys Res Commun       Date:  2005-02-18       Impact factor: 3.575

4.  Evidence that serotonin reuptake modulators increase the density of serotonin innervation in the forebrain.

Authors:  Lijun Zhou; Kai-Xing Huang; Alexsandar Kecojevic; Annie M Welsh; Vassilis E Koliatsos
Journal:  J Neurochem       Date:  2005-11-21       Impact factor: 5.372

5.  Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats.

Authors:  Patrick M Beardsley; James L Howard; Keith L Shelton; F Ivy Carroll
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

Review 6.  The olfactory bulbectomised rat as a model of depression.

Authors:  Cai Song; Brian E Leonard
Journal:  Neurosci Biobehav Rev       Date:  2005-04-25       Impact factor: 8.989

7.  Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning.

Authors:  Jay P McLaughlin; Benjamin B Land; Shuang Li; John E Pintar; Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2006-04       Impact factor: 7.853

8.  Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor.

Authors:  Andre L Curtis; Thelma Bethea; Rita J Valentino
Journal:  Neuropsychopharmacology       Date:  2006-03       Impact factor: 7.853

9.  Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system.

Authors:  Jay P McLaughlin; Shuang Li; Joseph Valdez; Theodore A Chavkin; Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2006-06       Impact factor: 7.853

10.  Identifying genes in monoamine nuclei that may determine stress vulnerability and depressive behavior in Wistar-Kyoto rats.

Authors:  Kimberly A Pearson; Alisson Stephen; Sheryl G Beck; Rita J Valentino
Journal:  Neuropsychopharmacology       Date:  2006-05-17       Impact factor: 7.853

View more
  64 in total

1.  Corticotropin-releasing factor in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility.

Authors:  Kevin Snyder; Wei-Wen Wang; Rebecca Han; Kile McFadden; Rita J Valentino
Journal:  Neuropsychopharmacology       Date:  2011-10-12       Impact factor: 7.853

Review 2.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

3.  Effect of adenoviral delivery of prodynorphin gene on experimental inflammatory pain induced by formalin in rats.

Authors:  Xionggang Chen; Tingting Wang; Caizhu Lin; Baihong Chen
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 4.  The impact of sex as a biological variable in the search for novel antidepressants.

Authors:  Alexia V Williams; Brian C Trainor
Journal:  Front Neuroendocrinol       Date:  2018-05-31       Impact factor: 8.606

Review 5.  The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Authors:  Sunmee Wee; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

6.  A role for the mu opioid receptor in the antidepressant effects of buprenorphine.

Authors:  Shivon A Robinson; Rebecca L Erickson; Caroline A Browne; Irwin Lucki
Journal:  Behav Brain Res       Date:  2016-11-03       Impact factor: 3.332

7.  Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.

Authors:  Caroline A Browne; Rebecca L Erickson; Julie A Blendy; Irwin Lucki
Journal:  Neuropharmacology       Date:  2017-02-07       Impact factor: 5.250

8.  Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats.

Authors:  Stephanie L Grella; Douglas Funk; Kathy Coen; Zhaoxia Li; A D Lê
Journal:  Behav Brain Res       Date:  2014-02-28       Impact factor: 3.332

Review 9.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

Review 10.  Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.

Authors:  Christopher R Bailey; Elisabeth Cordell; Sean M Sobin; Alexander Neumeister
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.